Iridex to Report Third Quarter 2026 Financial Results on November 17, 2026
Key Highlights
- ➤Iridex will release Q3 2026 financial results after market close November 17, 2026
- ➤Management will provide a business update during the November 17 conference call
- ➤Conference call begins at 2:00 p.m. PT / 5:00 p.m. ET
SAN JOSE, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader in innovative laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced plans to release financial results for the third quarter 2026 and provide a business update after the close of trading on November 17, 2026.
The Company’s management team will host a corresponding conference call beginning at 2:00 p.m. PT / 5:00 p.m. ET. Investors interested in listening to the conference call may do so by dialing +1-800-715-9871 from the US or +1-646-307-1963 internationally and providing Conference ID: 7118799. A live and recorded webcast will be available on the “Event Calendar” page of the “Investors” section of the Company’s website at www.iridex.com.
Get started
Create a free account to read the full story.